Do various imaging modalities provide potential early detection and diagnosis of medication-related osteonecrosis of the jaw? A review

P Wongratwanich, K Shimabukuro… - Dentomaxillofacial …, 2021 - academic.oup.com
Objective: Patients with medication-related osteonecrosis of the jaw (MRONJ) often visit their
dentists at advanced stages and subsequently require treatments that greatly affect quality of …

Osteomyelitis, osteoradionecrosis, or medication‐related osteonecrosis of the jaws? Can CBCT enhance radiographic diagnosis?

H Gaêta‐Araujo, O Vanderhaeghen… - Oral …, 2021 - Wiley Online Library
Objective To attempt defining differential radiographic diagnostic characteristics for
osteonecrotic lesions using 2D as opposed to 3D images. Materials and Methods This was a …

The value of diffusion-weighted imaging in the diagnosis of medication-related osteonecrosis of the jaws

H Muraoka, K Ito, N Hirahara, S Okada, T Kondo… - Oral Surgery, Oral …, 2021 - Elsevier
Objective The purpose of this study was to assess apparent diffusion coefficient (ADC)
values associated with medication-related osteonecrosis of the jaws (MRONJ) at each stage …

Correlation of dynamic contrast-enhanced bone perfusion with morphologic ultra-short echo time MR imaging in medication-related osteonecrosis of the jaw

P Schumann, S Morgenroth, FA Huber… - Dentomaxillofacial …, 2022 - academic.oup.com
Objectives: To investigate whether dynamic contrast-enhanced (DCE)-MR bone perfusion
could serve as surrogate for morphologic ultra-short echo time (UTE) bone images and to …

Comparative evaluation of SPECT/CT and CBCT in patients with mandibular osteomyelitis and osteonecrosis

J Malina-Altzinger, B Klaeser, VGA Suter… - Clinical oral …, 2019 - Springer
Objectives Therapy of osteomyelitis and osteonecrosis very often requires surgery. Proper
preoperative radiological evaluation of a lesion's localization and extent is a key in planning …

Why do some extraction sites develop medication-related osteonecrosis of the jaw and others do not? A within-patient study assessing radiographic predictors.

H Gaêta-Araujo, A Ferreira Leite… - … Journal of Oral …, 2021 - search.ebscohost.com
Purpose: To compare radiographic predictors of medication-related osteonecrosis of the jaw
in dental extraction sites. Materials and methods: Forty-one oncological patients undergoing …

[HTML][HTML] Tomographic study of Jaw bone changes in patients with bisphosphonate-related osteonecrosis

G Simpione, RJ Caldas, MQS Soares… - Journal of clinical and …, 2020 - ncbi.nlm.nih.gov
Background Bisphosphonates (BP) are synthetic pyrophosphate-like substances with
antiresorptive properties and specifically affect osteoclastic activity. In 2007, the American …

[HTML][HTML] A large animal model of periodontal defects in bisphosphonate-related osteonecrosis of the jaw: A comparison of clinical and radiological findings

M Otto, A Neff, T Ziebart, F Halling - Journal of Periodontal & Implant …, 2023 - jpis.org
Purpose The objective of this study was to demonstrate the suitability of cone-beam
computed tomography (CBCT) for in vivo research in periodontology, with implications for …

[HTML][HTML] Predictive factors for refractory stage i and ii anti-resorptive agent-related osteonecrosis of the jaw

T Shimizu, M Kim, TT Dam, J Kurihara, M Ogawa… - Oral Radiology, 2022 - Springer
Objectives We aimed to predict the possibility of patients with stage I and II anti-resorptive
agent-related osteonecrosis of the jaw (ARONJ) developing resistance to our treatment …

Suspected bisphosphate‐related osteonecrosis of the jaw in a cat being treated with alendronate for idiopathic hypercalcaemia

E Rogers‐Smith, N Whitley, C Elwood… - Veterinary Record …, 2019 - Wiley Online Library
An 8‐year‐old female neutered domestic shorthair diagnosed with idiopathic
hypercalcaemia and undergoing weekly treatment with alendronate presented to Davies …